Modern fasting guidelines in children

Scott D Cook-Sather1, Ronald S Litman

  • 1The Department of Anesthesiology and Critical Care Medicine, The University of Pennsylvania School of Medicine, The Children's Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA 19104-4399, USA. sather@email.chop.edu

Insights

Updated pediatric fasting guidelines allow clear liquids up to 2 hours before anesthesia, improving patient safety and perioperative experience. Shorter fasting times for breast milk, formula, and light meals are now well-established for healthy children.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Perioperative Medicine

Background:

  • Pediatric fasting guidelines aim to prevent pulmonary aspiration and ensure safe anesthesia.
  • Recent guideline revisions prioritize patient safety and enhance the perioperative experience for children and parents.
  • Established practice for nearly 15 years supports current guidelines.

Purpose of the Study:

  • To review the established safety and benefits of current pediatric fasting guidelines.
  • To highlight the evidence supporting shortened fasting intervals for various food types in children.
  • To identify areas where further research is needed regarding fasting in pediatric patients with gastrointestinal disorders.

Main Methods:

  • Review of accumulated clinical experience and existing literature on pediatric fasting.
  • Analysis of evidence regarding gastric fluid volumes (GFVs) at the time of surgery.
  • Assessment of the impact of updated guidelines on patient safety and perioperative experience.

Main Results:

  • Allowing clear liquids up to 2 hours prior to anesthesia is safe and beneficial for healthy children.
  • Shortened fasting periods of 3 hours for breast milk, 4 hours for formula, and 6 hours for light meals are supported by evidence.
  • Evidence indicates minimal gastric fluid volumes (GFVs) with current fasting protocols.

Conclusions:

  • Current pediatric fasting guidelines, including shortened intervals, are safe and effective for healthy children.
  • The updated guidelines contribute to an improved perioperative experience for pediatric patients and their families.
  • Further research is required to determine optimal fasting intervals for children with gastrointestinal transit disorders.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Metabolic States of the Body: Fasting and Starvation01:24

Metabolic States of the Body: Fasting and Starvation

During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...